The questions your broker hopes you never ask, answered straight.
The benefits industry is structurally designed to keep CFOs uninformed, because an informed CFO stops overpaying. This is the field guide to becoming informed.
Do employers actually have to offer health insurance?
Most of you don’t. The mandate applies at 50 full-time equivalents, part-timers count toward that math, which catches employers who assume they’re exempt, and even then it’s a penalty for not offering, not a law that requires it. Everyone under 50 offers coverage by choice, to compete for talent. Know which camp you’re in before you treat “we have to” as a reason for anything.
Why does my renewal go up every year, even when my employees barely used the plan?
Because in a fully-insured plan, your premium isn’t priced only on your claims. It’s priced on the carrier’s whole book, their trend assumptions, and their margin. A good year for your people doesn’t earn you a lower renewal. It means the carrier kept the difference. You’re funding a pool you can’t see and don’t control.
Claims, administration, network access fees, broker compensation, taxes, and carrier profit. In a fully-insured plan you get one number and no itemization. The entire model depends on you not asking for the breakdown, because once you see it, you start negotiating the parts.
What’s the difference between fully-insured and self-funded?
Fully-insured: you pay a fixed premium, the carrier takes the risk and keeps the surplus. Self-funded: you pay your own claims plus admin, insure the catastrophic ones, and keep the surplus yourself. Same care, same networks in most cases. The difference is who owns the upside. You or the carrier.
It’s more transparent, not more risky, when it’s built right. Stop-loss insurance caps your exposure on any single claim and in aggregate, so your worst case is a known, budgeted number. The real risk is staying fully-insured, calling a fixed premium “safe,” and overpaying for the privilege.
How do I know if my company is the right size to self-fund?
There’s no magic headcount, and the old “100 lives” rule is outdated, level-funded and captive structures make self-funding work well below that, and I work with groups starting around 40 employees. The real questions are your claims stability, your cash position, and your appetite to actually manage the plan. Size is a factor. It’s not the answer.
What actually changes, and what doesn’t, when I switch funding structures?
What changes: cash flow, transparency, and who keeps the surplus. What doesn’t: your employees’ cards, networks, and experience. Most CFOs brace for a disruption that never comes and miss the one to their P&L, which was the entire point.
What are the biggest myths CFOs believe about self-funding?
Four: that it’s only for huge companies, that one bad claim wipes you out, that employees will notice, and that fully-insured is “safer.” All four are marketed to you by the party that profits when you stay put.
If my broker never explained any of this, what does that tell me?
That the incentives worked the way they were built to. An informed employer renegotiates, shops, and self-funds; an uninformed one renews. That doesn’t make your broker a bad actor. It makes the compensation structure worth understanding. Ask why you’re only hearing this now.
What are all my funding options, from fully-insured to fully self-funded?
It’s a spectrum, not a switch: fully-insured, level-funded, self-funded with stop-loss, then group captive and other pooled structures at the sophisticated end. Each move hands more transparency and surplus to you, and asks more of you in return. The goal isn’t the far end. It’s the right point for your risk and appetite.
Is level-funding a real step toward self-funding, or a carrier trap?
Both, depending on the contract. Level-funding lets you self-fund with training wheels: a fixed monthly cost with a potential refund of surplus. The trap is in the fine print, so ask one specific question before you sign: is surplus calculated on claims incurred or claims paid? That single definition is where most level-funded refunds quietly disappear.
What’s the difference between a MEWA, a consortium, and a coalition?
All three pool separate employers so you can buy like one big one. The differences that matter are who you’re pooled with, how you exit, and who holds the money. MEWAs are state-regulated, and some have failed and left employers with unpaid claims, which is the real reason to ask about solvency and exit terms before you ask about savings.
How do I evaluate any pooled arrangement before joining?
Four questions, in writing, every time. Who else is in the pool and how are they underwritten? How are losses allocated if the group runs hot? What do I have to put in up front, and when do I get it back? And how do I leave, how much notice, and who pays my run-out claims? A good program answers all four on one page.
Which structure is the right fit for a company my size?
The honest answer: it depends on your claims profile, cash flow, and how hands-on you want to be. A stable 60-life group and a volatile 400-life group belong in different structures. Anyone who quotes you a structure before they’ve seen your data is selling, not advising.
What does “good” actually look like in a plan design?
Good is transparent, measurable, and built around your data, not the carrier’s book. You can see your claims, you know your fixed costs, your surplus comes back to you, and your advisor is paid by you. If you can’t explain where every dollar goes, it isn’t good yet. It’s familiar.
How often should I be re-evaluating my funding structure?
Every year at minimum, and not just by reading the renewal letter. Markets, your claims, and your headcount move. The structure that fit at 50 lives can be leaving money on the table at 150. Treat it like any other major line item: reviewed on a schedule, not on autopilot.
THE INSURANCE THAT TURNS UNLIMITED RISK INTO A BUDGETED CEILING
Q17–25
17
What is stop-loss insurance, and do I need it?
Stop-loss is the insurance behind self-funding. It caps what you pay on any one claimant (specific) and what you pay across the whole plan in a year (aggregate). If you self-fund, yes, you need it. It’s what turns “unlimited risk” into a budgeted, known ceiling.
What’s the difference between specific and aggregate stop-loss?
Specific protects you from one catastrophic claimant: a transplant, a NICU stay, a million-dollar drug. Aggregate protects you if the whole plan runs hot, lots of ordinary claims adding past expected. Specific is the lightning strike. Aggregate is the flood. You want coverage for both.
What do the contract terms mean — 12/12, 15/12, 24/12, 12/15?
It’s the contract’s claims window: the first number is how many months a claim can be incurred, the second how many months it can be paid. A 12/12 covers claims incurred and paid inside the year. A 15/12 or 24/12 adds run-in protection for claims from before the contract started. A 12/15 runs the other direction, claims incurred in the year and paid up to three months after it ends, which is the form you care about when you’re leaving a carrier, not arriving. The narrower the window, the more gap risk you’re quietly holding.
What is aggregate accommodation, and do I want it?
Aggregate accommodation means your stop-loss carrier reimburses you during the year when claims exceed the aggregate attachment point, instead of making you wait until the contract ends. Without it, you front the cash on a bad year and get paid back months later. It costs a modest amount of premium. For a first-time self-funder, it’s worth buying.
Fixed costs, administration, stop-loss premium, PBM fees, are predictable and billed monthly. Claims are variable: some months run under budget, some over, and you fund what’s actually incurred. You set a monthly funding rate that covers expected claims, and your good months bank against the bad ones. Ask for your maximum-liability number before you sign. That’s the true worst case, and it’s a figure you can put in a budget.
What is lasering, and how can it come back to bite me?
A laser is when your stop-loss carrier singles out a known high-cost claimant and sets a higher deductible just for them. It’s legal and common. The bite comes at renewal: a new laser, or a lasered claimant plus a rate hike, can blow up a budget you thought was locked. Negotiate laser terms and rate caps up front, not after you’re surprised.
What is run-in and run-out (IBNR) liability, and who pays for it?
Claims don’t stop when a contract ends. They’re incurred now and paid weeks or months later. Run-in covers claims from before your contract started; run-out covers claims incurred before it ended but paid after. Someone funds that tail. Make sure you know whether it’s you.
Terminal liability coverage extends your stop-loss to pay the run-out claims after you cancel a contract. If you ever plan to switch carriers or structures, and you should stay free to, it keeps you from paying that tail twice. It’s cheap insurance against being trapped. Usually worth it.
How do I keep my stop-loss carrier from repricing me after a bad year?
Negotiate rate caps and no-new-laser provisions before you sign, not after. A rate cap limits how much they can raise your rate at renewal; a no-laser clause stops them from singling out your sick claimants next year. Carriers offer these when you ask and you have leverage, which is before you’re locked in.
BUYING INSURANCE WHOLESALE, WITH OWNERS WHO SHARE THE GAME
Q26–33
26
What is a captive health plan, in plain terms?
A captive is a group of employers who pool their claims risk, buy reinsurance as a group, and share in the results. You get big-employer pricing and transparency without being a huge employer. Think of it as buying insurance wholesale, alongside other owners who have skin in the same game.
What’s the difference between a single-parent and a group captive?
A single-parent captive is your own: you fund it, you own it, and it’s built for very large employers. A group captive pools your risk with other mid-market employers under shared governance and reinsurance. For most companies in the 40 to 700 range, group is the realistic door. Single-parent is a different weight class.
Most group captives require a capital contribution, real money, held as your share of the risk pool. It’s typically returned when you exit in good standing, but it’s cash out of your account in year one and it belongs in the budget conversation from the start. Ask three things: the amount, the terms it’s held under, and exactly what triggers its return.
What is a captive feasibility study, and what should it actually tell me?
It’s the analysis that tells you whether a captive actually beats your current structure, using your real claims data, not a sales pitch. Done right, it shows your expected cost, your risk band, and your break-even under different scenarios. If it tells you only good news, it isn’t a study. It’s a brochure.
Am I giving up control by joining a group captive?
You’re trading a little autonomy for a lot of leverage and transparency. There’s shared governance and rules of the road, but you also see your data, keep your surplus, and gain pricing you couldn’t get alone. The control you “give up” is mostly control you never had in a fully-insured plan.
What happens if the captive has a bad claims year — am I on the hook for everyone else?
This is the fear, and it’s mostly a misread of how modern group captives are built. Your specific risk is capped, the group’s risk is reinsured, and losses are structured so one bad member doesn’t sink the rest. You share in results, but the downside is banded, not unlimited. Ask exactly how losses are allocated before you join.
Ask before you join, not after. Good exit terms are written, time-bounded, and answer three questions: how much notice you owe, what happens to your capital contribution, and who funds your run-out claims. Vague exit language is the single biggest red flag in any pooled arrangement.
A VEBA is a tax-advantaged trust that holds your health plan’s assets. It can smooth funding and add tax efficiency for the right employer, usually larger, stable groups with predictable claims. It’s a tool, not a default. It makes sense when the tax and funding math clearly clears the added complexity.
WHERE THE LEAST TRANSPARENT MONEY IN YOUR PLAN HIDES
Q34–44
34
Why are my prescription drug costs so high?
Because pharmacy is where the least transparent money in your plan hides. It’s not just drug prices: it’s spread pricing, retained rebates, and formulary games that steer patients to the most profitable drug, not the cheapest. Pharmacy is often the fastest-growing line in your plan, and the one your PBM is least eager to explain.
A PBM sits between your plan and the pharmacy, deciding what’s covered and at what price, and pocketing plenty along the way. You need the function. You don’t need the opaque, conflicted version of it. Transparent pass-through PBMs exist; most employers just don’t know to ask.
What is spread pricing, and how much is it quietly costing me?
Spread pricing is when your PBM charges you more for a drug than it pays the pharmacy, and keeps the difference. You’re billed $100, the pharmacy gets $60, the PBM pockets $40, and nobody tells you. Across a full plan that spread runs into six and seven figures. The fix is a pass-through contract where you pay the real price plus a disclosed fee.
What are rebates, and why am I not seeing all of mine?
Drug makers pay rebates for formulary placement, and those dollars are supposed to lower your cost. How much reaches you depends entirely on contract language most employers never read: your PBM can keep a share, or define “rebate” narrowly enough to keep most of it. If you don’t know your rebate pass-through percentage, assume it isn’t 100%.
Cover, exclude, or apply criteria, but pick deliberately, because the default is expensive. Blanket coverage can move your pharmacy line fast; a blanket exclusion creates a recruiting and morale problem you will hear about. Most employers land in the middle: clinical criteria, prior authorization, and a required adherence component. Decide it as a budget question with a policy attached, not as a formulary accident.
What’s a biosimilar, and why isn’t my plan using them?
A biosimilar is a near-identical, lower-cost version of a biologic. Same clinical effect, a fraction of the price. Your plan may not be using them because the higher-priced brand carries a bigger rebate, and rebates flow to whoever builds the formulary. Ask what share of your biologic spend has a biosimilar available, and what share is actually being dispensed. The gap between those two numbers is money.
What are copay accumulators and maximizers, and why are my employees upset?
They change whether manufacturer copay assistance counts toward your employee’s deductible. Under an accumulator it doesn’t, so the member hits a bill they never saw coming once the assistance runs out; a maximizer spreads the assistance across the year instead. Both save the plan real money and both generate real member complaints. If you run one, the fix is communication before January, not after the first angry call.
What is a pharmacy carve-out, and should I consider one?
A carve-out pulls pharmacy out of your medical carrier’s bundle and contracts it separately, usually with a transparent PBM. It trades a little convenience for a lot of visibility and control over your fastest-growing cost. For most self-funded mid-market employers, it’s worth pricing out. The bundle is convenient for the carrier, not for your budget.
Yes, and expect resistance. Your audit right is exactly what the opaque model relies on you never using. A real audit checks whether you actually got the pricing, rebates, and terms your contract promised, and it routinely finds money. If your PBM makes auditing hard, you’ve learned something before the audit starts.
What’s driving my specialty drug spend, and can I control it?
Specialty drugs are a small share of scripts and a huge share of spend, driven by high-cost biologics, generous formulary placement, and site-of-care markups. You can control it: clinical review, site-of-care steering, alternative sourcing, and copay assistance. It takes an advisor willing to manage it, not just pass the bill through.
Why does the same drug cost wildly different amounts under my plan?
Because the price under your plan has little to do with the drug and a lot to do with where it’s filled, how it’s coded, and what your PBM decided to charge. Same molecule, different site of care, different markup. That variation isn’t a glitch. It’s the business model. Transparency is how you flatten it.
How does my broker actually get paid, and by whom?
Most brokers are paid by the carrier: a commission baked into your premium, plus bonuses you never see. That means the party advising you on your spend is paid more when your spend goes up. It’s not necessarily malice. It’s a structural conflict, and federal law entitles you to the exact number, because the CAA requires written disclosure of both direct and indirect compensation. Follow the check.
What are contingent commissions and overrides, and should I be worried?
These are bonuses carriers pay brokers for hitting volume or retention targets across their whole book, money that has nothing to do with serving you and everything to do with keeping business placed. Be aware, not paranoid. Ask your broker to disclose every dollar of carrier compensation, contingent included.
What’s the difference between a commission-based broker and a fee-based advisor?
A commission-based broker is paid by the carrier, as a slice of your premium. A fee-based advisor is paid by you, a flat, disclosed amount, so their incentive is to lower your cost, not preserve it. Same title on the door, opposite economics behind it. Know which one you’re paying, and how.
How do I know if my broker is actually shopping the market for me?
Ask to see the marketing: which carriers they approached, what came back, and why they recommended what they did. A broker shopping the market can show you the spread. One who isn’t will hand you a renewal and a reassurance. “Trust me, this is the best option” is not a market check.
An RFP is a structured bid where you put your benefits program out to competing advisors and carriers. Run one when you haven’t tested the market in three years, when your costs are climbing, or when you just want to know if you’re being served. It’s not disloyal. It’s due diligence, and the best advisors welcome it.
What should I be asking my broker every single year?
Five questions, same five, every year. What are you paid on this account, and by whom? What’s my actual claims experience, not just the renewal number? Did you market my plan, and to whom? What’s my total cost of healthcare per employee, and how is it trending? And what would you change if this were your money? Watch whether the answers get sharper or vaguer.
Disclosed in writing, before we start: every dollar, every carrier, base plus overrides, bonuses, and contingents. Where my compensation would change based on what I’m recommending, moving you off fully-insured, for instance, I show you the delta so you can weight the advice accordingly. The CAA requires the disclosure. I treat it as the start of the relationship, not a compliance box. Ask me for the number and you’ll have it.
If you’re self-funded, it’s your plan and your data: claims, utilization, high-cost claimants (de-identified as required), pharmacy detail, all of it. Under the CAA’s gag-clause prohibition, your right to your own information is stronger than ever. If a vendor treats your data as theirs to ration, that’s a red flag about the whole relationship.
Because data is leverage, and leverage is easier to keep if you don’t have it. Carriers and some TPAs make data access slow, partial, or expensive, not because they can’t share it, but because an employer who can read their own claims starts making decisions the carrier would rather make for them. Push. It’s yours.
What are the few data points every plan sponsor should watch?
Total cost per employee per year and its trend. Large-claim frequency and severity. Pharmacy as a share of total spend. Your fixed-cost ratio. And your surplus or deficit against expected. Five numbers, reviewed every quarter, tell you more than a hundred-page renewal deck.
You don’t need a PhD. You need the five numbers above and someone to frame them. If your advisor can’t turn your data into a one-page story, get one who can.
Medical loss ratio is the share of your premium the carrier actually paid out in claims. Large group carries an 85% floor, but rebates are calculated across the carrier’s whole book, not your group, so a genuinely good claims year usually earns you nothing. Ask for three years of MLR. If your loss ratio ran well under the floor and no rebate ever arrived, you funded someone’s margin and called it insurance.
What does it mean to run my health plan like a P&L?
It means treating your plan as what it is, often your second- or third-largest expense, with the same rigor you’d apply to any line on your P&L. Known inputs, measured outputs, variance you can explain, and decisions driven by data instead of a renewal letter. You’d never run a department this blindly.
We have a high-cost claimant — what are our options?
More options than the carrier will volunteer: specialty-drug sourcing, site-of-care steering, case management, centers of excellence, and making sure your stop-loss is filed correctly and on time. The worst move is to do nothing and absorb it. A high-cost claimant is a management problem, not just a bill.
How do I benchmark my plan against peer companies?
Against real peer data, same size, industry, and region, not a national average that hides more than it shows. Good benchmarking tells you whether your cost per employee, your trend, and your plan richness are ahead of or behind comparable employers. It turns “our costs went up” into “our costs went up more than they should have,” the sentence that drives action.
Everything: claims, premiums or funding, admin, stop-loss, pharmacy, fees, and the compensation buried in all of it, divided by your employees. Most CFOs can quote their premium and not their total cost. The gap between those two numbers is where the overpayment lives. Find your real number first.
What is Direct Primary Care (DPC), and does it actually save money?
DPC is a flat monthly fee for a primary-care doctor with real access: longer visits, direct messaging, no per-visit billing. It can save money by catching problems early and cutting downstream claims, specialist visits, and ER use. It’s not a silver bullet, and it isn’t free. But for the right population, the claims math works.
What’s the difference between DPC and Advanced Primary Care (APC)?
DPC is the membership model: flat fee, direct relationship, usually independent practices. APC is the broader idea, primary care built around outcomes and total-cost management, often integrated with your plan and data. DPC is a delivery model; APC is a strategy. They overlap, and the marketing blurs them, so ask what you’re actually buying.
What is care navigation, and is it different from what my carrier offers?
Navigation means the member calls a nurse before they schedule, and that nurse routes them to a high-quality provider at a contracted price. Done right, the member’s cost is waived, no copay, no deductible, and the plan pays dramatically less than network pricing. It’s the rare strategy where the member and the plan both win. Ask any vendor for their engagement rate, because navigation nobody uses saves nothing.
Count them. PCP, telemedicine, carrier navigation, nurse line, urgent care, ER, a musculoskeletal vendor, a diabetes vendor, HR, if an employee with back pain doesn’t know which one to call, you’re paying for capability that never changes behavior. More vendors is not better navigation. Sometimes the fix is fewer doors.
Usually yes, and ask this first, because it’s the question your employees will ask. Most self-funded plans rent the same major networks, so the cards change and the doctors don’t. Before you move, run a disruption analysis against your actual claims: which providers your people used, and whether they’re in the new network. Don’t accept a provider count. Ask about your providers.
Why aren’t my employees using the preventive benefits I’m already paying for?
Because access, friction, and awareness beat good intentions every time. If it’s hard to get an appointment, unclear what’s free, or nobody reminded them, they won’t go, and you pay for the expensive version later. Preventive care is only a savings strategy if people actually use it. Engagement is the missing half of the ROI.
What is a Center of Excellence, and is it worth steering employees to one?
A Center of Excellence is a facility with proven outcomes for specific high-cost procedures: joint replacements, cardiac, transplants. Steering employees there, often with travel covered, buys better outcomes and lower total cost at the same time. For procedures where quality varies wildly and mistakes are expensive, yes, it’s worth it.
What is network adequacy, and how do I know if mine is any good?
Network adequacy is whether your employees can actually get the care they need, in-network, without a long drive or a long wait. A big network on paper means nothing if the right specialists aren’t in it or aren’t taking patients. Test it against where your people live and what they actually need, not the carrier’s provider count.
Every consultant is pitching DPC — what does the data actually say?
The data says DPC helps, for the right population, implemented well, and measured honestly. It’s not magic, and it’s not for everyone. When a whole industry pitches one solution, it’s usually because it’s easy to sell, not because it fits every plan. Ask for your projected impact on your claims, not the vendor’s national case study.
WHERE THE REAL ECONOMICS LIVE, WRITTEN TO BE SKIMMED
Q70–74
70
What words should I be looking for buried in my carrier contract?
The ones that quietly move money and risk to you: “shared savings,” “access fees,” “discount guarantees” with carve-outs, and definitions of “covered” that shrink when it matters. The contract is where the real economics live, and it’s written to be skimmed. Three words in the wrong clause can cost you more than a whole renewal negotiation.
What is a shared-savings fee, and why am I paying for savings that don’t exist?
A shared-savings fee lets a vendor take a percentage of the “savings” they claim to generate, often measured against an inflated benchmark they set. So you pay a fee on savings that may be partly fiction, calculated by the party collecting the fee. Ask exactly how the baseline is defined. If they set the baseline and take a cut, the incentive writes itself.
How does a $500K claim end up costing me far more than $500K?
Through markups, fees, and financing stacked on top of the actual care. A large claim runs through networks, vendors, and “savings” programs, each taking a percentage, and a poorly structured stop-loss or contract can multiply what should have been a bounded cost. The care cost $500K. The system’s take is what turns it into something far larger. That’s a contract problem, not a medical one.
It depends entirely on 47% off of what. A big discount off an inflated chargemaster can still leave you paying more than a smaller discount off a fair price. Carriers love to sell the discount percentage because it sounds like a win while hiding the base price. Ask for the net cost, not the discount. The percentage is theater.
How do I offer better benefits without increasing my budget?
By reallocating what you already spend. Most plans leak money on spread, retained rebates, opaque fees, and inefficient care delivery, money that, once recovered, funds richer benefits at the same or lower cost. The budget usually isn’t too small. It’s poorly deployed. Fix the leaks and you’ll find room you didn’t know you had.
What are my fiduciary responsibilities as an employer sponsoring a health plan?
Under ERISA you’re a fiduciary, legally required to run the plan in your employees’ best interest and control costs prudently. That means knowing what you pay, why, and whether it’s reasonable. Health plans got a pass that retirement plans didn’t. That era is ending, and “I trusted my broker” is not a defense.
What did the CAA of 2021 change, and why should I care?
The Consolidated Appropriations Act stripped away the excuse of not knowing. It requires broker and vendor compensation disclosure, bans gag clauses on your own claims data, and reinforces your fiduciary duty to police plan costs. Translation: you now have both the right to the information and the obligation to act on it.
What compliance deadlines am I actually on the hook for?
More than most mid-market sponsors realize. The recurring list: the gag clause attestation, RxDC prescription drug reporting, Form 5500 and the summary annual report, your mental health parity comparative analysis, a current Section 125 plan document if you pre-tax premiums, and an SPD distributed on schedule. None of these are hard. All of them are documented failures if you skip them.
What’s a gag clause attestation, and why does it matter?
The CAA bans contract language that stops you from seeing your own claims and pricing data, and each year you must attest that none of your vendor contracts contain it. Most sponsors sign it having never read the underlying contracts, which means they’re certifying something they can’t defend. Read the contracts before you sign the attestation.
What is the J&J / ERISA lawsuit, and could it happen to me?
It’s a class action alleging the employer breached its fiduciary duty by overpaying for prescription drugs, brought by its own employees. The case was dismissed on Article III standing, not on the merits, which means the underlying duty was never tested and the next plaintiff will fix the standing problem. If a Fortune 50 with a full benefits team draws that suit, a mid-market employer on autopilot isn’t safe by being smaller.
How do I document that I’m meeting my fiduciary duty?
Build a paper trail that shows prudence: a benefits committee with minutes, documented vendor and broker compensation, a record that you benchmarked and marketed the plan, and a process for reviewing fees. Fiduciary duty is about process, not perfect outcomes. If you can show you asked the right questions and acted reasonably, you’re in a very different position than the sponsor who can’t.
What’s the single biggest compliance blind spot for mid-market employers?
Assuming the broker or carrier has it handled. Fiduciary duty can’t be outsourced: you can hire help, but the legal responsibility stays with you. Most mid-market sponsors have never seen their vendors’ full compensation or documented a single prudent process. That gap, not any one filing, is the exposure.
What is an ICHRA, and how is it different from a traditional group plan?
An ICHRA, individual coverage HRA, lets you give employees tax-free dollars to buy their own individual health insurance instead of you sponsoring one group plan. You fund a defined contribution; they choose the plan. It shifts you from managing a plan to funding a benefit. For some employers that’s freedom. For others it’s a headache in disguise.
Could an ICHRA actually work for my company, or is it just hype?
It works in specific situations: a distributed workforce, wildly different employee needs, or a strong individual market in your area. It’s oversold as a universal fix. Whether it fits depends on your geography, your population, and your tolerance for the administrative and employee-experience realities. Run the scenario on your actual workforce before you believe the pitch.
An ICHRA is affordable only if your contribution leaves the employee’s share of the lowest-cost silver plan in their area under the ACA threshold, and that threshold has moved, changing the math on every contribution decision you make this fall. Affordability varies by employee age and ZIP code, so it isn’t one number, it’s a calculation per person. Run it on your actual census before you set the contribution.
Because they’re sold as “set a budget and walk away,” and that’s not how they land. They fail on weak individual markets, poor communication, sticker shock at enrollment, and no support when employees have to shop alone. The concept is sound. The execution is where it dies.
Group purchasing leverage, plan-design control, and a simple, familiar employee experience. You trade the predictability of one negotiated group plan for individual-market variability your employees now navigate. Sometimes that trade is worth it. But go in knowing what you’re handing over, not just what you’re hoping to save.
What is reference-based pricing (RBP), and how does it actually work?
RBP throws out the carrier’s negotiated network pricing and pays providers a set multiple of Medicare instead. It can cut costs dramatically, because it refuses to pay inflated chargemaster rates. The trade-off is active management and real member support, done well it’s powerful, done cheaply it puts your employees in the middle.
It’s the number-one fear, and a well-run program is built specifically to handle it, with member advocacy, legal support, and provider agreements that head off balance bills before they reach an employee. Balance billing happens when RBP is implemented cheaply, without that support layer. The model isn’t the risk. Cutting corners on the support is.
When does RBP make sense versus a traditional network?
When your costs are high, your claims are dominated by facility spend, and you have the appetite for a more hands-on model with strong member support. It makes less sense for smaller groups or ones that want a hands-off experience. RBP is a strategy, not a plug-in: right for the employer ready to manage it, wrong for the one who wants to set it and forget it.
Less than you fear, if it’s planned. Vendor setup, TPA, stop-loss, PBM, care navigation, data analytics, starts roughly 90 days before your effective date. Your team’s job is light: current plan data, decisions at a few defined checkpoints, and enrollment logistics. The real risks are data errors in file transfers and confused employees, and both are managed with a calendar.
You don’t flip one switch. Crawl: get off the carrier’s terms and get real transparency into your own data. Walk: add stop-loss, carve out pharmacy, look at a captive. Run: direct contracts, reference-based pricing, on-site or virtual primary care. It’s a three-to-five-year path, and step one is simply knowing your true total cost per employee.
What should I have in hand before my next renewal conversation?
Four things: your last 36 months of claims data, your total cost per employee, your broker’s compensation in writing, and the five-number breakdown of your renewal increase, medical trend, Rx trend, demographics, plan design, and carrier margin. Walk in with those and the conversation changes. Walk in with a renewal letter and you’ll get a renewal.
Healthcare cost analysis for employers who treat benefits as capital allocation. If your situation doesn't fit neatly into one of these ninety-two answers, that is usually the most interesting conversation to have.
This FAQ is educational and general in nature. It is not legal, tax, or specific plan advice. · Tess McCoy, MS, CEBS, CSFS · Employee Benefits Consultant, Hotchkiss Insurance · Health Plan Decoded · The Benefits Brief